| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 166,300 | 69,370 | 90,723 | 174,699 | | Cost of Revenue | 121,089 | 61,822 | 91,587 | 153,072 | | | Gross Profit | 45,211 | 7,548 | (864) | 21,627 | | | Operating Expenses | | Research Development | 3,028 | 3,170 | 5,269 | 4,207 | | Selling General and Administrative | 20,271 | 13,056 | 15,489 | 21,271 | | Non Recurring |
-
|
-
| 1,750 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,912 | (8,678) | (23,372) | (3,851) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 4 | 1 | 17 | | Earnings Before Interest And Taxes | 21,912 | (8,674) | (23,371) | (3,834) | | Interest Expense | 175 | 72 | 74 | 323 | | Income Before Tax | 21,737 | (8,746) | (23,445) | (4,157) | | Income Tax Expense | 6,957 | (2,799) | (6,709) | (1,433) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 14,780 | (5,947) | (16,736) | (2,724) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,780 | (5,947) | (16,736) | (2,724) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $14,780 | ($5,947) | ($16,736) | ($2,724) |
|
0.12% Nasdaq 
0.30%
Income Statement
